A single intradiscal glucocorticoid injection reduced discopathy-related low back pain at 1 month; however, the effect decreased over time. At 12 months, neither pain intensity nor other ...
At the 11th Annual Orthopedic, Spine and Pain Management-Driven ASC Conference, in Chicago, Timothy T. Davis, MD, will give a presentation titled “Intradiscal Biologics Injections for Mild to Moderate ...
Sufferers of chronic lower back pain are often given an epidural injection if simple painkillers, stretching exercises or good posture fail. Pain in the lower back is particularly common but generally ...
The PP353 clinical trial met the primary endpoint and demonstrated statistically significant, clinically meaningful and durable reduction in pain and disability in patients with chronic Low Back Pain ...
HOUSTON--(BUSINESS WIRE)--MRI analysis of patients who received intradiscal injections of human dermal fibroblasts (HDFs) shows significant improvement in disc height after six months. This is the ...
Please provide your email address to receive an email when new articles are posted on . Intradiscal steroid injections may offer short-term pain relief in patients with discogenic low back pain and ...
HealthDay News — For patients with chronic low back pain (LBP) with active discopathy, a single glucocorticoid intradiscal injection (GC IDI) is associated with reduced LBP at one month but not 12 ...
In conjunction with La Peer Surgery Center in Beverly Hills, Calif., orthopedic surgeon, Steven Meier, MD, performed the first outpatient stem cell lumbar intradiscal injection and platelet rich ...
Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back Pain The PP353 clinical trial met the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback